Necrobiosis lipoidica is a rare, chronic skin condition that produces distinctive yellowish-brown, waxy-looking plaques, most often on the shins. Although it has long been associated with diabetes, roughly four out of ten people who develop it have no diabetes at all. The condition is frustrating for patients and clinicians alike: it tends to resist treatment, can ulcerate painfully, and its exact cause remains debated even after nearly a century of study.
What Necrobiosis Lipoidica Looks Like
The hallmark is a well-defined plaque on the lower leg that starts as a small, reddish-brown papule or nodule and gradually expands outward. Over months to years, the center of the plaque thins and takes on a shiny, yellowish or waxy tone, while the border stays raised and darker. Tiny blood vessels become visible through the thinned skin, giving it a characteristic web of fine red lines (telangiectasias). The medical description sums it up as yellow-brown, atrophic, telangiectatic plaques on the lower extremities with underlying collagen damage and inflammation in the deeper skin layers.1PubMed Central. A case series and literature review of necrobiosis lipoidica
Although the shins are by far the most common location, lesions can appear on the thighs, abdomen, upper arms, and even the scalp.2PubMed Central. Necrobiosis lipoidica diabeticorum: A case-based review of literature Many people have lesions on both legs. In early stages, the patches may look like a bruise or an insect bite, which is part of why diagnosis is sometimes delayed. In later stages, the plaques are usually unmistakable: the thin, glassy skin stretched over visible vessels is unlike most other dermatological conditions.
The Diabetes Connection, and Its Limits
For decades, this condition was called necrobiosis lipoidica diabeticorum, reflecting the assumption that diabetes was a prerequisite. That name began losing favor after case reports of non-diabetic patients accumulated from the 1930s onward. The first non-diabetic case was documented by Goldsmith in 1935, and by the mid-twentieth century enough additional cases had appeared that clinicians proposed dropping “diabeticorum” from the name entirely.3PubMed. Necrobiosis Lipoidica Today, “necrobiosis lipoidica” is the standard term, covering patients with and without diabetes.
Still, the association with diabetes is real and substantial. Among people who have diabetes, the condition affects a small fraction, roughly 0.3% of diabetic patients according to available estimates.4PubMed Central. Necrobiosis lipoidica diabeticorum: A case-based review of literature But in a large study of people with necrobiosis lipoidica, about 41% did not have diabetes, and their blood sugar levels were normal.5JAMA Dermatology. Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes So while having diabetes increases your risk, you absolutely can develop this condition with perfectly healthy blood sugar.
In people who do have diabetes, worse glycemic control appears to matter. A study of patients with type 1 diabetes found that those who developed necrobiosis lipoidica had higher average blood sugar levels and needed more insulin than those who did not develop it.6PubMed. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus Whether tightening blood sugar control can reverse existing lesions is a separate question, and one where the evidence is thin. A systematic review found that among a small group of patients, some saw their lesions improve after intensifying diabetes management, including a handful who received pancreas transplants, but the review’s own conclusion was that there is currently insufficient evidence to say glycemic control reliably helps.7PubMed. A systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patients with diabetes mellitus
Other Health Conditions That Show Up Alongside It
Diabetes gets most of the attention, but the same large study that documented the 41% non-diabetic rate also found that necrobiosis lipoidica patients carried a heavy burden of other metabolic and cardiovascular risk factors. About 45% had high blood pressure, 44% had dyslipidemia, and roughly a quarter had thyroid disease. Over half were obese, and the obesity rates were nearly identical whether or not the patient also had diabetes.8JAMA Dermatology. Clinical Features and Comorbidities of Patients With Necrobiosis Lipoidica With or Without Diabetes This cluster of metabolic findings has led some researchers to argue that necrobiosis lipoidica is better understood as a condition linked to metabolic dysfunction broadly rather than to diabetes specifically.
There are also rarer overlaps. Necrobiosis lipoidica-like lesions have been documented in people with systemic sarcoidosis, where the skin changes can mimic the classic appearance closely enough to cause diagnostic confusion.9PubMed Central. Necrobiosis lipoidica-like lesions in a nondiabetic patient with systemic sarcoidosis: A case report and review of the literature This overlap is uncommon, but it matters because the treatment strategies differ.
What Causes the Skin Damage
The honest answer is that nobody knows for certain. The most widely discussed theory centers on microangiopathy, or damage to the small blood vessels that nourish the skin. In this model, thickened or dysfunctional small vessels reduce blood flow to the dermis, triggering collagen breakdown and the inflammatory process that produces the characteristic plaques.10PubMed. Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options This theory fits neatly with the diabetes link, since diabetes is well known to damage small blood vessels throughout the body.
But microangiopathy alone does not explain the full picture, particularly the large proportion of patients without diabetes. Immune-mediated inflammation clearly plays a role: biopsies show immune cells clustering in the skin in patterns that resemble a granulomatous reaction, meaning the immune system is mounting an organized inflammatory response against something in the tissue. Some researchers think the immune component may be primary, with the vascular changes following rather than leading. In teenagers with type 1 diabetes and necrobiosis lipoidica, researchers have observed that the lesions appear despite very little time for the kind of cumulative small-vessel damage seen in long-standing diabetes, which has fueled the hypothesis that hyperglycemia itself, rather than chronic vascular injury, may be the more direct trigger in at least some patients.11JAAD Case Reports. Pediatric necrobiosis lipoidica: Adults and kids are not the same
How It Is Diagnosed
In many cases, experienced dermatologists can recognize necrobiosis lipoidica on sight: the combination of location, color, atrophic center, and visible vessels is quite distinctive. When the presentation is less clear-cut, a skin biopsy is the standard confirmatory test. Under the microscope, the pattern of layered collagen breakdown (necrobiosis) with surrounding inflammation arranged in a palisading granulomatous pattern is characteristic.
Dermoscopy has emerged as a useful non-invasive tool. When viewed under a dermatoscope, necrobiosis lipoidica shows elongated, branching, serpentine blood vessels over a whitish, structureless background. This pattern is distinct from the dermoscopic appearance of granuloma annulare, a condition that can look similar to the naked eye but shows different vessel patterns under magnification.12Dermatology. Dermoscopy of Necrobiosis Lipoidica and Granuloma Annulare Dermoscopy does not replace biopsy in ambiguous cases, but it can help clinicians decide whether a biopsy is worth pursuing and can speed up diagnosis in settings where biopsy turnaround is slow.13PubMed Central. Necrobiosis lipoidica: A case report with dermoscopic review
The differential diagnosis mainly includes granuloma annulare, which shares some microscopic features but tends to present as ring-shaped, flesh-colored bumps without the same degree of atrophy and telangiectasia.14JAMA Dermatology. NECROBIOSIS LIPOIDICA (DIABETICORUM?): A Histologic Study and Comparison with Granuloma Annulare Other conditions on the list include morphea, stasis dermatitis, and, in atypical locations, sarcoidosis.
First-Line Treatment With Topical Therapies
There is no single therapy that reliably clears necrobiosis lipoidica, and no treatment has been validated by large randomized controlled trials. Most evidence comes from case reports, small case series, and retrospective reviews. With that caveat firmly in place, topical corticosteroids are the most commonly used first-line treatment. Potent formulations applied up to twice daily can reduce inflammation and slow lesion progression, particularly when lesions are caught early.15PubMed. Necrobiosis lipoidica in childhood: a review of literature with emphasis on therapy Intralesional steroid injections are also used, especially for thicker, more active plaques. The risk with long-term steroid use on already-thin skin is further atrophy, so clinicians tend to limit duration and potency.
Topical calcineurin inhibitors, particularly tacrolimus, have become a popular second option. These drugs suppress the local immune response without thinning the skin the way steroids do, making them safer for prolonged use on fragile tissue. Case reports and small series suggest tacrolimus works best on newer, non-ulcerated lesions.16PubMed Central. Necrobiosis Lipoidica: Early Diagnosis and Treatment with Tacrolimus A systematic review found that 11 of 17 patients treated with topical calcineurin inhibitors showed improvement, putting them among the better-performing options in the admittedly limited evidence base.17PubMed. Treatment options for necrobiosis lipoidica: a systematic review
Compression therapy also deserves mention. The same systematic review found improvement in 15 of 20 patients treated with compression, which makes sense given the lower-leg location and the likely role of venous insufficiency and poor circulation in perpetuating lesions. Simple compression stockings or bandaging carry minimal risk and are sometimes used alongside other therapies.
Light-Based and Laser Treatments
When topical approaches fall short, light-based therapies are an increasingly common next step. Photodynamic therapy, or PDT, involves applying a light-sensitizing cream to the skin and then exposing it to a specific wavelength of light. A systematic review identified PDT as having the largest body of evidence among all treatments, with improvement documented in 72 of 80 patients across published reports.18PubMed. Treatment options for necrobiosis lipoidica: a systematic review That sounds impressive, but publication bias is a real concern: case reports that show improvement are far more likely to be written up than those that do not.
A real-world multicenter study helped calibrate expectations. Among 17 patients treated with PDT over a ten-year period, about 29% achieved what the researchers called complete clearance (greater than 75% reduction), while 59% had a partial response and 12% did not respond at all.19PubMed Central. Shedding Light on Photodynamic Therapy in the Treatment of Necrobiosis Lipoidica: A Multicenter Real-Life Experience So PDT helps most patients to some degree but is far from a guaranteed cure.
Other light and laser modalities have been explored. Pulsed dye laser, which targets blood vessels, has shown consistently positive results across published reports, though the total number of patients studied remains small. PUVA therapy, which combines a photosensitizing drug called psoralen with ultraviolet A light, has the longest track record in the literature. UVA1 phototherapy without psoralen has also been used. A review of laser and light therapies found that pulsed dye laser stood out for its consistency, while PUVA had the most published studies to draw from.20PubMed. Laser and light therapies for the treatment of necrobiosis lipoidica
Systemic Drugs and Biologics for Stubborn Cases
Because the microangiopathy theory has been influential, drugs that affect blood flow have been tried. Pentoxifylline, a medication that improves circulation by reducing blood viscosity and platelet clumping, showed promising results in a case report: a young woman with diabetes saw her lesions stop growing after one month and nearly resolve after six months of treatment, remaining in remission at two years.21PubMed. Necrobiosis lipoidica diabeticorum: response to pentoxiphylline Low-dose aspirin, another drug that affects blood flow, was studied in a small trial but actually appeared to reduce blood flow in the affected skin, leading the investigators to conclude it may not be a good choice.22PubMed. Skin blood flow in necrobiosis lipoidica during treatment with low-dose acetylsalicylic acid
For lesions that resist everything else, immunosuppressants like cyclosporine and fumaric acid esters have been tried, as have TNF-alpha inhibitors such as adalimumab, etanercept, and infliximab. A recent review identified newer biologics and Janus kinase inhibitors, including ustekinumab and secukinumab, as potentially effective for recalcitrant disease.23PubMed Central. A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation These are heavy-duty medications with significant side-effect profiles, and the evidence supporting their use in necrobiosis lipoidica consists almost entirely of case reports. They represent a last resort rather than a standard pathway, but for patients with painful, ulcerated, or rapidly expanding lesions, they offer at least the possibility of control.
When Surgery Becomes an Option
Surgical excision is reserved for large, treatment-resistant plaques, particularly those that have ulcerated or cause significant pain. The approach typically involves removing the affected skin down to the deep fascia, ligating the perforating blood vessels in the area, and covering the defect with a skin graft.24PubMed. The surgical treatment of necrobiosis lipoidica diabeticorum Staged excisions, where the lesion is removed in phases rather than all at once, have been described as an approach for very large plaques in patients with high cosmetic expectations. One case report detailed successful treatment using a dermal template and full-thickness skin grafts to achieve a good aesthetic result in a young woman.25PubMed Central. Necrobiosis Lipoidica Affecting the Leg: What Is the Best Treatment in a Patient with Very High Aesthetic Demand?
Surgery does carry the risk of recurrence at the graft site, and wound healing can be slower in patients with diabetes or compromised circulation. It is generally not offered unless medical therapies have been exhausted.
Complications Worth Watching For
The most common complication is ulceration. When the skin thins enough, even minor trauma can break it open, and ulcerated necrobiosis lipoidica lesions are notoriously slow to heal. Pain tends to escalate significantly once ulceration occurs, and the open wound carries a risk of secondary infection. Some patients experience intense itching or abnormal sensations like burning or tingling even without ulceration.26PubMed Central. A case series and literature review of necrobiosis lipoidica
A much rarer but more serious risk is the development of squamous cell carcinoma within a long-standing lesion. Like burn scars and chronic ulcers, the persistent scarring and tissue turnover in necrobiosis lipoidica can create an environment where skin cancer develops. Published cases of this transformation exist, and at least one report describes a fatal outcome in a patient with type 1 diabetes whose squamous cell carcinoma arose within a plaque that had been present for over a decade.27PubMed Central. Fatal squamous cell carcinoma from necrobiosis lipoidica diabeticorum in a diabetic patient This is exceedingly rare, but it does mean that any new growth, nodule, or change within an existing lesion deserves prompt medical evaluation rather than being dismissed as part of the usual disease course.
Necrobiosis Lipoidica in Children and Teenagers
The condition is less common in children than in adults, but when it does appear, it has some distinguishing features. Pediatric cases are more strongly associated with diabetes than adult cases, and the typical patient is a teenage girl with type 1 diabetes and poor glycemic control.28JAAD Case Reports. Pediatric necrobiosis lipoidica: Adults and kids are not the same Treatment in younger patients is also more constrained because some systemic therapies carry risks that are harder to justify in a growing body. A review of pediatric cases found that potent topical steroids remain the first choice, with tacrolimus as the go-to alternative for cases that do not respond.29PubMed. Necrobiosis lipoidica in childhood: a review of literature with emphasis on therapy
The fact that teenagers with relatively short diabetes duration develop necrobiosis lipoidica is itself scientifically interesting. These patients have not had enough time to develop the kind of widespread small-vessel damage seen in adults with decades of diabetes, yet they develop the same skin lesions. This observation has pushed some researchers to rethink the microangiopathy model and consider that acute metabolic disruption, particularly high circulating glucose, might be capable of initiating the process on its own.
Living With a Condition That Resists Easy Answers
Beyond the physical symptoms, necrobiosis lipoidica takes a genuine psychological toll. The plaques are visible, cosmetically distressing, and sit on parts of the body that are hard to conceal in warm weather. The condition is chronic and frequently resistant to treatment, which creates a cycle of frustration: patients try a therapy, see partial or no improvement, and face the prospect of trying yet another option with similarly modest odds of success. One case report specifically noted that achieving remission “relieved psychological stress” for the patient, treating psychological burden as an outcome worth documenting alongside the physical findings.30PubMed. Necrobiosis lipoidica diabeticorum: response to pentoxiphylline
Multidisciplinary management involving dermatology, endocrinology, and sometimes plastic surgery tends to produce the best outcomes, partly because no single specialty has all the answers and partly because addressing the metabolic context alongside the skin disease can improve overall trajectory. Wound care specialists may also play a role when ulceration develops. The condition is rarely life-threatening, but describing it as merely cosmetic dramatically undersells the pain, the functional limitation from leg ulcers, and the emotional weight of a chronic, visible illness that most people, including many doctors, have never heard of.